International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Nov 12, 2021, after the close
10-Q filed Nov 12, 2021, 43 days after period end · 0001564590-21-056695
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $1.84M | $1.48M | $2.10M | $3.20M |
| Net Income | -$165.00K | -$544.00K | $3.00K | $121.00K |
| EPS Diluted | -$0.02 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.07 |
| $0.00 |
| $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
